The effect of intranasal oxytocin versus placebo treatment on the autonomic responses to human sounds in autism: A single-blind, randomized, placebo-controlled, crossover design study

I. Fan Lin, Makio Kashino, Haruhisa Ohta, Takashi Yamada, Masayuki Tani, Hiromi Watanabe, Chieko Kanai, Taisei Ohno, Yuko Takayama, Akira Iwanami, Nobumasa Kato

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Many individuals with autism spectrum disorders (ASD) have difficulty with verbal communication, which might be due to a lack of spontaneous orientation toward social auditory stimuli. Previous studies have shown that a single dose of oxytocin improves speech comprehension in autism. The primary aim of this study was to investigate whether the orientation behaviors toward human sounds are different for neurotypical (NT) adults and adults with ASD and whether oxytocin has an effect on their orientation behaviors toward human sounds. Methods. This was a randomized, placebo-controlled, within-subject, crossover design study of intranasal oxytocin versus placebo in 13 NT adults and 16 adults with ASD. Subjects were randomized to 24 IU intranasal oxytocin or placebo on different days, and they were blind to the treatment. The participants then listened passively to human and non-human affective sounds while their skin conductance responses (SCRs) and the changes in peripheral blood vessel constriction were monitored as an indicator of spontaneous orientation. The monitored data were analyzed by a mixed-design ANOVA. Results: Oxytocin enhanced the difference between the SCRs to human and non-human sounds in both the NT and ASD groups (F(1,56) = 6.046, p = 0.017). Further correlation coefficient analysis showed significant correlations between this SCR difference and the scores in the autism spectrum quotient 'attention to detail' and 'social skill' subscales and interpersonal reactivity index and social functioning scale in the ASD group. Oxytocin was well tolerated, and no serious adverse effects were reported. Conclusions: The difference in SCRs implies that oxytocin nasal spray may enhance orientation behaviors toward human sounds in the presence of other environmental sounds in both ASD and NT adults. Trial registration. UMIN-CTR Clinical Trial, Unique trial number: UMIN000005809.

Original languageEnglish
Article number20
JournalMolecular Autism
Volume5
Issue number1
DOIs
Publication statusPublished - Feb 28 2014
Externally publishedYes

Fingerprint

Oxytocin
Autistic Disorder
Cross-Over Studies
Placebos
Skin
Therapeutics
Nasal Sprays
Constriction
Blood Vessels
Autism Spectrum Disorder
Analysis of Variance
Communication
Clinical Trials

Keywords

  • Auditory
  • Autism
  • Autonomic system
  • Clinical trial
  • Oxytocin
  • Skin conductance response
  • Social cognition

ASJC Scopus subject areas

  • Molecular Biology
  • Developmental Neuroscience
  • Developmental Biology
  • Psychiatry and Mental health

Cite this

The effect of intranasal oxytocin versus placebo treatment on the autonomic responses to human sounds in autism : A single-blind, randomized, placebo-controlled, crossover design study. / Lin, I. Fan; Kashino, Makio; Ohta, Haruhisa; Yamada, Takashi; Tani, Masayuki; Watanabe, Hiromi; Kanai, Chieko; Ohno, Taisei; Takayama, Yuko; Iwanami, Akira; Kato, Nobumasa.

In: Molecular Autism, Vol. 5, No. 1, 20, 28.02.2014.

Research output: Contribution to journalArticle

Lin, I. Fan ; Kashino, Makio ; Ohta, Haruhisa ; Yamada, Takashi ; Tani, Masayuki ; Watanabe, Hiromi ; Kanai, Chieko ; Ohno, Taisei ; Takayama, Yuko ; Iwanami, Akira ; Kato, Nobumasa. / The effect of intranasal oxytocin versus placebo treatment on the autonomic responses to human sounds in autism : A single-blind, randomized, placebo-controlled, crossover design study. In: Molecular Autism. 2014 ; Vol. 5, No. 1.
@article{b512fb9d574948fea0cd430288a13f83,
title = "The effect of intranasal oxytocin versus placebo treatment on the autonomic responses to human sounds in autism: A single-blind, randomized, placebo-controlled, crossover design study",
abstract = "Background: Many individuals with autism spectrum disorders (ASD) have difficulty with verbal communication, which might be due to a lack of spontaneous orientation toward social auditory stimuli. Previous studies have shown that a single dose of oxytocin improves speech comprehension in autism. The primary aim of this study was to investigate whether the orientation behaviors toward human sounds are different for neurotypical (NT) adults and adults with ASD and whether oxytocin has an effect on their orientation behaviors toward human sounds. Methods. This was a randomized, placebo-controlled, within-subject, crossover design study of intranasal oxytocin versus placebo in 13 NT adults and 16 adults with ASD. Subjects were randomized to 24 IU intranasal oxytocin or placebo on different days, and they were blind to the treatment. The participants then listened passively to human and non-human affective sounds while their skin conductance responses (SCRs) and the changes in peripheral blood vessel constriction were monitored as an indicator of spontaneous orientation. The monitored data were analyzed by a mixed-design ANOVA. Results: Oxytocin enhanced the difference between the SCRs to human and non-human sounds in both the NT and ASD groups (F(1,56) = 6.046, p = 0.017). Further correlation coefficient analysis showed significant correlations between this SCR difference and the scores in the autism spectrum quotient 'attention to detail' and 'social skill' subscales and interpersonal reactivity index and social functioning scale in the ASD group. Oxytocin was well tolerated, and no serious adverse effects were reported. Conclusions: The difference in SCRs implies that oxytocin nasal spray may enhance orientation behaviors toward human sounds in the presence of other environmental sounds in both ASD and NT adults. Trial registration. UMIN-CTR Clinical Trial, Unique trial number: UMIN000005809.",
keywords = "Auditory, Autism, Autonomic system, Clinical trial, Oxytocin, Skin conductance response, Social cognition",
author = "Lin, {I. Fan} and Makio Kashino and Haruhisa Ohta and Takashi Yamada and Masayuki Tani and Hiromi Watanabe and Chieko Kanai and Taisei Ohno and Yuko Takayama and Akira Iwanami and Nobumasa Kato",
year = "2014",
month = "2",
day = "28",
doi = "10.1186/2040-2392-5-20",
language = "English",
volume = "5",
journal = "Molecular Autism",
issn = "2040-2392",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The effect of intranasal oxytocin versus placebo treatment on the autonomic responses to human sounds in autism

T2 - A single-blind, randomized, placebo-controlled, crossover design study

AU - Lin, I. Fan

AU - Kashino, Makio

AU - Ohta, Haruhisa

AU - Yamada, Takashi

AU - Tani, Masayuki

AU - Watanabe, Hiromi

AU - Kanai, Chieko

AU - Ohno, Taisei

AU - Takayama, Yuko

AU - Iwanami, Akira

AU - Kato, Nobumasa

PY - 2014/2/28

Y1 - 2014/2/28

N2 - Background: Many individuals with autism spectrum disorders (ASD) have difficulty with verbal communication, which might be due to a lack of spontaneous orientation toward social auditory stimuli. Previous studies have shown that a single dose of oxytocin improves speech comprehension in autism. The primary aim of this study was to investigate whether the orientation behaviors toward human sounds are different for neurotypical (NT) adults and adults with ASD and whether oxytocin has an effect on their orientation behaviors toward human sounds. Methods. This was a randomized, placebo-controlled, within-subject, crossover design study of intranasal oxytocin versus placebo in 13 NT adults and 16 adults with ASD. Subjects were randomized to 24 IU intranasal oxytocin or placebo on different days, and they were blind to the treatment. The participants then listened passively to human and non-human affective sounds while their skin conductance responses (SCRs) and the changes in peripheral blood vessel constriction were monitored as an indicator of spontaneous orientation. The monitored data were analyzed by a mixed-design ANOVA. Results: Oxytocin enhanced the difference between the SCRs to human and non-human sounds in both the NT and ASD groups (F(1,56) = 6.046, p = 0.017). Further correlation coefficient analysis showed significant correlations between this SCR difference and the scores in the autism spectrum quotient 'attention to detail' and 'social skill' subscales and interpersonal reactivity index and social functioning scale in the ASD group. Oxytocin was well tolerated, and no serious adverse effects were reported. Conclusions: The difference in SCRs implies that oxytocin nasal spray may enhance orientation behaviors toward human sounds in the presence of other environmental sounds in both ASD and NT adults. Trial registration. UMIN-CTR Clinical Trial, Unique trial number: UMIN000005809.

AB - Background: Many individuals with autism spectrum disorders (ASD) have difficulty with verbal communication, which might be due to a lack of spontaneous orientation toward social auditory stimuli. Previous studies have shown that a single dose of oxytocin improves speech comprehension in autism. The primary aim of this study was to investigate whether the orientation behaviors toward human sounds are different for neurotypical (NT) adults and adults with ASD and whether oxytocin has an effect on their orientation behaviors toward human sounds. Methods. This was a randomized, placebo-controlled, within-subject, crossover design study of intranasal oxytocin versus placebo in 13 NT adults and 16 adults with ASD. Subjects were randomized to 24 IU intranasal oxytocin or placebo on different days, and they were blind to the treatment. The participants then listened passively to human and non-human affective sounds while their skin conductance responses (SCRs) and the changes in peripheral blood vessel constriction were monitored as an indicator of spontaneous orientation. The monitored data were analyzed by a mixed-design ANOVA. Results: Oxytocin enhanced the difference between the SCRs to human and non-human sounds in both the NT and ASD groups (F(1,56) = 6.046, p = 0.017). Further correlation coefficient analysis showed significant correlations between this SCR difference and the scores in the autism spectrum quotient 'attention to detail' and 'social skill' subscales and interpersonal reactivity index and social functioning scale in the ASD group. Oxytocin was well tolerated, and no serious adverse effects were reported. Conclusions: The difference in SCRs implies that oxytocin nasal spray may enhance orientation behaviors toward human sounds in the presence of other environmental sounds in both ASD and NT adults. Trial registration. UMIN-CTR Clinical Trial, Unique trial number: UMIN000005809.

KW - Auditory

KW - Autism

KW - Autonomic system

KW - Clinical trial

KW - Oxytocin

KW - Skin conductance response

KW - Social cognition

UR - http://www.scopus.com/inward/record.url?scp=84897991188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897991188&partnerID=8YFLogxK

U2 - 10.1186/2040-2392-5-20

DO - 10.1186/2040-2392-5-20

M3 - Article

AN - SCOPUS:84897991188

VL - 5

JO - Molecular Autism

JF - Molecular Autism

SN - 2040-2392

IS - 1

M1 - 20

ER -